Dr. Todd Wolf

Patrick Forde is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Forde is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, and Small Cell Lung Cancer (SCLC). Dr. Forde is currently accepting new patients.

It’s important that the treatment experience is as personal and comfortable as possible for every family. Our department has its own Family Advisory Council whose input helped bring lots of improvements – like room service, refrigerators, prayer groups, better food, and better access to social support. Making life easier for these families is a huge priority for me. Even sick kids are kids at heart (as I am), just looking for a smile, some fun, a connection with the team members who take care of them. I make it my business to make life better for these kids and their families – as a doctor and through research into promising new drugs. I’m a firm believer in clinical trials. In fact, about 80% of our patients are enrolled in clinical trials through the Nemours Center for Cancer and Blood Disorders, and the Nemours Center for Childhood Cancer Research, where I’m director of both. This number is much higher than for adults with cancer, and much higher for children with other kinds of diseases. We also participate in the national Pediatric Preclinical Testing Program, which makes new therapies available for kids sooner. In our department, participating in clinical trials and research studies is the standard of our family-centered care. Dr. Kolb is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Leukemia, Rhabdomyosarcoma, and Bone Marrow Transplant. Dr. Kolb is currently accepting new patients.

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine. Dr. Brodsky is currently accepting new patients.